Sandbox AG: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
=Encephalitis Table= | =Encephalitis Table= | ||
Reference list includes:<ref name="pmid21932127">{{cite journal| author=Eckstein C, Saidha S, Levy M| title=A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis. | journal=J Neurol | year= 2012 | volume= 259 | issue= 5 | pages= 801-16 | pmid=21932127 | doi=10.1007/s00415-011-6240-5 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21932127 }} </ref> | |||
*Demyelination disorders (MS, ADEM) | *Demyelination disorders (MS, ADEM) | ||
Line 22: | Line 24: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[Demyelinating disease]]s''' | | style="padding: 5px 5px; background: #DCDCDC;" | '''[[Demyelinating disease]]s''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[ | | style="padding: 5px 5px; background: #F5F5F5;" |[[Multiple sclerosis]]: Typically well-demarcated ovoid lesions with possible T1 hypointensities (“black holes”) | ||
[[Acute disseminated encephalomyelitis]]: diffuse or multi-lesion enhancement, with indistinct lesion borders | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[ | | style="padding: 5px 5px; background: #DCDCDC;" | '''[[Substance abuse]]''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Varying depending on type of substance: prior history, drug-seeking behavior, attention-seeking behavior, [[paranoia]], sudden [[panic]], [[anxiety]] | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[Yellow fever]] and other [[Flaviviridae]] ''' | | style="padding: 5px 5px; background: #DCDCDC;" | '''[[Yellow fever]] and other [[Flaviviridae]] ''' |
Revision as of 13:08, 26 April 2016
Encephalitis Table
Reference list includes:[1]
- Demyelination disorders (MS, ADEM)
- Substance Abuse
- Electrolyte imbalance (hypo/hyper natremia)
- Stroke
- Brain Hemmhorage
- Trauma
- Tumor
Disease | Findings |
---|---|
Meningitis | Photophobia, phonophobia, rash associated with meningococcemia, concomitant sinusitis or otitis |
Brain abscess | Varying depending on the location of the abscess; generally, on imaging, a lesion demonstrates both ring enhancement and central restricted diffusion |
Demyelinating diseases | Multiple sclerosis: Typically well-demarcated ovoid lesions with possible T1 hypointensities (“black holes”)
Acute disseminated encephalomyelitis: diffuse or multi-lesion enhancement, with indistinct lesion borders |
Substance abuse | Varying depending on type of substance: prior history, drug-seeking behavior, attention-seeking behavior, paranoia, sudden panic, anxiety |
Yellow fever and other Flaviviridae | Present with hemorrhagic complications. Epidemiological investigation may reveal a pattern of disease transmission by an insect vector. Virus isolation and serological investigation serves to distinguish these viruses. Confirmed history of previous yellow fever vaccination will rule out yellow fever. |
Shigellosis & other bacterial enteric infections | Presents with diarrhea, possibly bloody, accompanied by fever, nausea, and toxemia, vomiting, cramps, and tenesmus. Stools contain blood and mucous in a typical case. A search for possible sites of bacterial infection, together with cultures and blood smears, should be made. Presence of leukocytosis distinguishes bacterial infections from viral infections. |
Ebola | Presents with fever, chills vomiting, diarrhea, generalized pain or malaise, and internal and external bleeding, that follow an incubation period of 2-21 days. |
Others | Scarlet fever, leptospirosis, viral hepatitis, typhus, and mononucleosis can produce signs and symptoms that may be confused with rheumatic fever in early stages of infection. |
- ↑ Eckstein C, Saidha S, Levy M (2012). "A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis". J Neurol. 259 (5): 801–16. doi:10.1007/s00415-011-6240-5. PMID 21932127.